BACKGROUND: Nijmegen breakage syndrome (NBS) is an autosomal-recessive chromosome instability disorder characterized by, among others, hypersensitivity to X-irradiation and an exceptionally high risk for lymphoid malignancy. The vast majority of NBS patients is homozygous for a common Slavic founder mutation, c.657del5, of the NBN gene, which is involved in the repair of DNA double-strand breaks (DSBs). The founder mutation also predisposes heterozygous carriers to cancer, apparently however, with a higher risk in the Czech Republic/Slovakia (CS) than in Poland. AIM: To examine whether the age of cancer manifestation and cancer death of NBN homozygotes is different between probands from CS and Poland. METHODS: The study is restricted to probands born until 1989, before replacement of the communist regime by a democratic system in CS and Poland, and a substantial transition of the health care systems. Moreover, all patients were recruited without knowledge of their genetic status since the NBN gene was not identified until 1998. RESULTS: Here, we show that cancer manifestation of NBN homozygotes is at a significantly earlier age in probands from CS than from Poland. This is explained by the difference in natural and medical radiation exposure, though within the permissible dosage. CONCLUSION: It is reasonable to assume that this finding also sheds light on the higher cancer risk of NBN heterozygotes in CS than in Poland. This has implications for genetic counseling and individualized medicine also of probands with other DNA repair defects.

Department of Clinical Genetics Institute of Biology and Medical Genetics 2nd Medical School Charles University Prague Czech Republic

Department of Medical Genetics The Children's Memorial Health Institute Warsaw Poland

DNA Laboratory Department of Pediatric Neurology 2nd Medical School Charles University University Hospital Motol Prague Czech Republic

Institute of Medical and Human Genetics Charité Universitätsmedizin Berlin Berlin Germany

Zobrazit více v PubMed

Chrzanowska KH, Gregorek H, Dembowska‐Baginska B, Kalina MA, Digweed M. Nijmegen breakage syndrome (NBS). Orphanet J Rare Dis. 2012;7:13. PubMed PMC

Varon R, Vissinga C, Platzer M, et al. Nibrin, a novel DNA double‐strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell. 1998;93:467‐476. PubMed

Digweed M, Sperling K. Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double‐strand breaks. DNA Repair (Amst). 2004;3:1207‐1217. PubMed

Lamarche BJ, Orazio NI, Weitzman MD. The MRN complex in double‐strand break repair and telomere maintenance. FEBS Lett. 2010;584:3682‐3695. PubMed PMC

Komatsu K. NBS1 and multiple regulations of DNA damage response. J Radiat Res. 2016;57(Suppl 1):i11‐i17. PubMed PMC

Syed A, Tainer JA. The MRE11‐RAD50‐NBS1 complex conducts the orchestration of damage signaling and outcomes to stress in DNA replication and repair. Annu Rev Biochem. 2018;87:263‐294. PubMed PMC

Gao P, Ma N, Li M, Tian QB, Liu DW. Functional variants in NBS1 and cancer risk: evidence from a meta‐analysis of 60 publications with 111 individual studies. Mutagenesis. 2013;28:683‐697. PubMed

Seemanová E, Jarolim P, Seeman P, et al. Cancer risk of heterozygotes with the NBN founder mutation. J Natl Cancer Inst. 2007;99:1875‐1880. PubMed

Chrzanowska K, Pietkutowska‐Abramczuk D, Varon R, et al. Cancer risk and fertility of NBS heterozygotes in Poland. Abstract. Casopis Lekaru Ceskych. 2002;141:IX.

Steffen J, Varon R, Mosor M, et al. Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland. Int J Cancer. 2004;111(1):67‐71. PubMed

Seemanová E, Hoch J, Herzogová J, et al. Mutations in tumor suppressor gene NBS1 in adult patients with malignancies. Cas Lek Cesk. 2006;145:201‐203. PubMed

Sagan A, Panteli D, Borkowski W, et al. Poland health system review. Health Syst Transit. 2011;13:1‐193. PubMed

Alexa J, Rečka L, Votápková J, et al. Czech Republic: health system review. Health Syst Transit. 2015;17:1‐165. PubMed

Seeman P, Gebertová K, Paderová K, Sperling K, Seemanová E. Nijmegen breakage syndrome in 13% of age‐matched Czech children with primary microcephaly. Pediatr Neurol. 2004;30:195‐200. PubMed

Varon R, Seemanova E, Chrzanowska K, et al. Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three Slav populations. Eur J Hum Genet. 2000;8:900‐902. PubMed

Weemaes CM, Hustinx TW, Scheres JM, et al. A new chromosomal instability disorder: the Nijmegen breakage syndrome. Acta Paediatr Scand. 1981;70:557‐564. PubMed

Seemanová E, Passarge E, Beneskova D, et al. Familial microcephaly with normal intelligence, immunodeficiency, and risk for lymphoreticular malignancies: a new autosomal recessive disorder. Am J Med Genet. 1985;20:639‐648. PubMed

Chrzanowska KH, Digweed M, Sperling K, Seemanova E. DNA‐repair deficiency and cancer: lessons from lymphoma. In: Allgayer H, Rehder H, Fulda S, eds. Hereditary Tumors. From Genes to Clinical Consequences. WILEY‐VH; 2009:377‐391.

Nijmegen breakage syndrome . The International Nijmegen Breakage Syndrome Study Group. Arch Dis Child. 2000;82:400‐406. PubMed PMC

Neubauer S, Arutyunyan R, Stumm M, et al. Radiosensitivity of ataxia telangiectasia and Nijmegen breakage syndrome homozygotes and heterozygotes as determined by three‐color FISH chromosome painting. Radiat Res. 2002;157:312‐321. PubMed

Kuechler A, Neubauer S, Grabenbauer GG, et al. Is 24‐color FISH detection of in‐vitro radiation‐induced chromosomal aberrations suited to determine individual intrinsic radiosensitivity? Strahlenther Onkol. 2002;178:209‐215. PubMed

Leung CT, Yang Y, Yu KN, et al. Low‐dose radiation can cause epigenetic alterations associated with impairments in both male and female reproductive cells. Front Genet. 2021;12:710143. PubMed PMC

Wolska‐Kusnierz B, Pastorczak A, Fendler W, et al. Hematopoietic stem cell transplantation positively affects the natural history of cancer in Nijmegen breakage syndrome. Clin Cancer Res. 2021;27:575‐584. PubMed

Sharapova SO, Pashchenko OE, Bondarenko AV, et al. Geographical distribution, incidence, malignancies, and outcome of 136 Eastern Slavic patients with Nijmegen breakage syndrome and NBN founder variant c.657_661del5. Front Immunol. 2021;11:602482. PubMed PMC

Deripapa E, Balashov D, Rodina Y, et al. A prospective study of a cohort of Russian Nijmegen breakage syndrome patients demonstrating predictive value of low kappa‐deleting recombination excision circle (KREC) numbers and beneficial effect of hematopoietic stem cell transplantation (HSCT). Front Immunol. 2017;8:807. PubMed PMC

Seemanova E, Varon R, Vejvalka J, et al. The Slavic NBN founder mutation: a role for reproductive fitness? PLoS One. 2016;11:e0167984. PubMed PMC

Cinelli G, de Cort M, Tollefsen T, eds. Digital version of the European atlas of natural radiation. European Atlas of Natural Radiation. Publication Office of the European Union; 2019.

Cinelli G, Tollefsen T, Bossew P, et al. Digital version of the European Atlas of natural radiation. J Environ Radioact. 2019;196:240‐252. PubMed PMC

Bekas M, Gajewski AK, Pachoki K. How often are X‐rays used as diagnostic tool by healthcare providers in the Mazovian province of Poland. Rocz Panstw Zakl Hig. 2013;64:155‐160. PubMed

United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) . Source and Effects of Ionizing Radiation. Annex A. Vol I. United Nations; 2010.

Pasqual E, Turner MC, Gracia‐Lavedan E, et al. Association of ionizing radiation dose from common medical diagnostic procedures and lymphoma risk in the Epilymph case‐control study. PLoS One. 2020;15:e0235658. PubMed PMC

Meyn MS. Chromosome instability syndromes: lessons for carcinogenesis. Curr Top Microbiol Immunol. 1997;221:71‐148. PubMed